Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-04-25

Clinical Trial Update: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation [NA]

View source ↗

Summary

A clinical trial comparing CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy after transcatheter aortic valve implantation in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Antonius Hospital | Conditions: Severe Aortic Valve Stenosis | NA | Status: RECRUITING